JD HEALTH
06618
TRIP.COM-S
09961
NTES-S
09999
ALI HEALTH
00241
MEITUAN-W
03690
(Q6)Jun 30, 2024 | (FY)Dec 31, 2023 | (Q6)Jun 30, 2023 | (FY)Dec 31, 2022 | (Q6)Jun 30, 2022 | (FY)Dec 31, 2021 | (Q6)Jun 30, 2021 | (FY)Dec 31, 2020 | (Q6)Jun 30, 2020 | (FY)Dec 31, 2019 | |
---|---|---|---|---|---|---|---|---|---|---|
Turnover | 137.19%2.72B | 168.73%7.27B | 125.29%1.15B | 121.11%2.71B | -6.36%509.66M | 327.98%1.22B | 2,087.29%544.26M | 439.43%286.06M | -4.97%24.88M | 4.77%53.03M |
Operating income | 137.19%2.72B | 168.73%7.27B | 125.29%1.15B | 121.11%2.71B | -6.36%509.66M | 327.98%1.22B | 2,087.29%544.26M | 439.43%286.06M | -4.97%24.88M | 4.77%53.03M |
Cost of sales | -138.35%-2.14B | -140.23%-6.2B | -191.20%-897.39M | -225.64%-2.58B | 12.69%-308.17M | -375.97%-792.6M | -483,406.85%-352.96M | -40,220.10%-166.52M | 78.84%-73K | 81.45%-413K |
Operating expenses | -138.35%-2.14B | -140.23%-6.2B | -191.20%-897.39M | -225.64%-2.58B | 12.69%-308.17M | -375.97%-792.6M | -483,406.85%-352.96M | -40,220.10%-166.52M | 78.84%-73K | 81.45%-413K |
Gross profit | 133.05%584.55M | 752.86%1.07B | 24.48%250.82M | -70.83%125.94M | 5.33%201.5M | 261.12%431.66M | 671.07%191.3M | 127.18%119.54M | -3.98%24.81M | 8.73%52.62M |
Selling expenses | -40.46%-242.36M | -106.94%-639.06M | -83.74%-172.54M | 14.81%-308.81M | 53.33%-93.91M | -167.68%-362.49M | -5,962.67%-201.22M | ---135.42M | ---3.32M | ---- |
Administrative expenses | -128.92%-82.74M | 44.16%-118.96M | 64.14%-36.15M | -77.91%-213.02M | -86.26%-100.81M | -153.10%-119.74M | -617.42%-54.12M | -267.98%-47.31M | -62.34%-7.54M | -12.28%-12.86M |
Revaluation surplus | 98.92%-859K | -2,369.92%-132.88M | -558.16%-79.48M | -74.38%5.85M | 15,589.29%17.35M | 220.18%22.85M | 99.73%-112K | -133.79%-19.01M | -374.80%-41.99M | 9.44%56.27M |
-Changes in the fair value of investment property | 98.92%-859K | -2,369.92%-132.88M | -558.16%-79.48M | -74.38%5.85M | 15,589.29%17.35M | 220.18%22.85M | 99.73%-112K | -133.79%-19.01M | -374.80%-41.99M | 9.44%56.27M |
Special items of operating profit | 1.05%5.01M | 626.63%53.84M | 63.95%4.95M | 48.12%7.41M | 93.78%3.02M | 142.67%5M | 112.62%1.56M | -458.50%-11.72M | -3,522.87%-12.35M | 50.13%-2.1M |
Operating profit | 913.81%263.6M | 161.94%237M | -219.28%-32.39M | -1,584.46%-382.62M | 143.38%27.16M | 75.82%-22.72M | -54.93%-62.59M | -200.00%-93.92M | -211.81%-40.4M | 11.62%93.93M |
Financing cost | 10.29%-105.47M | 35.82%-261.17M | 12.23%-117.57M | -128.75%-406.94M | -95.25%-133.96M | -111.76%-177.9M | -1,095.26%-68.61M | -83,080.20%-84.01M | -10,336.36%-5.74M | ---101K |
Earning before tax | 205.45%158.13M | 96.94%-24.17M | -40.41%-149.96M | -293.57%-789.57M | 18.60%-106.8M | -12.75%-200.62M | -184.36%-131.2M | -289.64%-177.94M | -227.89%-46.14M | 11.50%93.83M |
Tax | -959.32%-142.48M | -147.29%-49.63M | 1,244.69%16.58M | 253.78%104.95M | -93.82%1.23M | 91.74%29.66M | 708.35%19.94M | 254.08%15.47M | 248.08%2.47M | -446.60%-10.04M |
After-tax profit from continuing operations | 111.74%15.65M | 89.22%-73.79M | -26.35%-133.38M | -300.48%-684.62M | 5.11%-105.57M | -5.22%-170.95M | -154.76%-111.26M | -293.91%-162.47M | -226.92%-43.67M | 1.79%83.79M |
Earning after tax | 111.74%15.65M | 89.22%-73.79M | -26.35%-133.38M | -300.48%-684.62M | 5.11%-105.57M | -5.22%-170.95M | -154.76%-111.26M | -293.91%-162.47M | -226.92%-43.67M | 1.79%83.79M |
Minority profit | 114.96%2.43M | 79.06%-43.7M | 48.67%-16.26M | -317.51%-208.65M | -7.73%-31.67M | -77.46%-49.98M | -5,998.55%-29.4M | ---28.16M | ---482K | ---- |
Profit attributable to shareholders | 111.29%13.22M | 93.68%-30.09M | -58.49%-117.13M | -293.44%-475.97M | 9.73%-73.9M | 9.92%-120.98M | -89.54%-81.86M | -260.29%-134.3M | -225.52%-43.19M | 1.79%83.79M |
Dividend per share | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 0.00%0.01 |
Basic earnings per share | 111.64%0.017 | 93.61%-0.038 | -58.70%-0.146 | -294.04%-0.595 | 9.80%-0.092 | 10.12%-0.151 | -88.89%-0.102 | -260.00%-0.168 | -225.58%-0.054 | 1.94%0.105 |
Diluted earnings per share | 111.64%0.017 | 93.61%-0.038 | -58.70%-0.146 | -294.04%-0.595 | 9.80%-0.092 | 10.12%-0.151 | -88.89%-0.102 | -260.00%-0.168 | -225.58%-0.054 | 1.94%0.105 |
Currency Unit | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD |
Accounting Standards | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS |
Audit Opinions | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion |
Auditor | -- | Ernst & Young | -- | Ernst & Young | -- | Ernst & Young | -- | Ernst & Young | -- | Ernst & Young |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.